Tissue Engineering and Regenerative Medicine: History, Progress, and Challenges

被引:494
作者
Berthiaume, Francois [1 ]
Maguire, Timothy J. [1 ]
Yarmush, Martin L. [1 ,2 ]
机构
[1] Rutgers State Univ, Dept Biomed Engn, Piscataway, NJ 08854 USA
[2] Massachusetts Gen Hosp, Ctr Engn Med, Boston, MA 02114 USA
来源
ANNUAL REVIEW OF CHEMICAL AND BIOMOLECULAR ENGINEERING, VOL 2 | 2011年 / 2卷
关键词
artificial organs; skin; cartilage; liver; stem cells; EMBRYONIC STEM-CELLS; AUTOLOGOUS CHONDROCYTE IMPLANTATION; HUMAN ARTICULAR CHONDROCYTES; FULMINANT HEPATIC-FAILURE; HUMAN EPIDERMAL-CELLS; TERM-FOLLOW-UP; IN-VITRO; BIOARTIFICIAL LIVER; CARTILAGE DEFECTS; SKIN SUBSTITUTES;
D O I
10.1146/annurev-chembioeng-061010-114257
中图分类号
O69 [应用化学];
学科分类号
070301 [无机化学];
摘要
The past three decades have seen the emergence of an endeavor called tissue engineering and regenerative medicine in which scientists, engineers, and physicians apply tools from a variety of fields to construct biological substitutes that can mimic tissues for diagnostic and research purposes and can replace (or help regenerate) diseased and injured tissues. A significant portion of this effort has been translated to actual therapies, especially in the areas of skin replacement and, to a lesser extent, cartilage repair. A good amount of thoughtful work has also yielded prototypes of other tissue substitutes such as nerve conduits, blood vessels, liver, and even heart. Forward movement to clinical product, however, has been slow. Another offshoot of these efforts has been the incorporation of some new exciting technologies (e.g., microfabrication, 3D printing) that may enable future breakthroughs. In this review we highlight the modest beginnings of the field and then describe three application examples that are in various stages of development, ranging from relatively mature (skin) to ongoing proof-of-concept (cartilage) to early stage (liver). We then discuss some of the major issues that limit the development of complex tissues, some of which are fundamentals-based, whereas others stem from the needs of the end users.
引用
收藏
页码:403 / 430
页数:28
相关论文
共 170 条
[1]
Engineering liver therapies for the future [J].
Allen, JW ;
Bhatia, SN .
TISSUE ENGINEERING, 2002, 8 (05) :725-737
[2]
Renal therapy using tissue-engineered constructs and gene delivery [J].
Amiel, GE ;
Yoo, JJ ;
Atala, A .
WORLD JOURNAL OF UROLOGY, 2000, 18 (01) :71-79
[3]
[Anonymous], 2010, Spinal Cord Injury Facts and Figures at a Glance
[4]
Tissue-engineered autologous bladders for patients needing cystoplasty [J].
Atala, A ;
Bauer, SB ;
Soker, S ;
Yoo, JJ ;
Retik, AB .
LANCET, 2006, 367 (9518) :1241-1246
[5]
Polymeric Substrates with Tunable Elasticity and Nanoscopically Controlled Biomolecule Presentation [J].
Aydin, Daniel ;
Louban, Ilia ;
Perschmann, Nadine ;
Bluemmel, Jacques ;
Lohmueller, Theobald ;
Cavalcanti-Adam, Elisabetta Ada ;
Haas, Tobias L. ;
Walczak, Henning ;
Kessler, Horst ;
Fiammengo, Roberto ;
Spatz, Joachim P. .
LANGMUIR, 2010, 26 (19) :15472-15480
[6]
Moving towards in situ tracheal regeneration: the bionic tissue engineered transplantation approach [J].
Bader, Augustinus ;
Macchiarini, Paolo .
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE, 2010, 14 (07) :1877-1889
[7]
Preincubation of tissue engineered constructs enhances donor cell retention [J].
Ball, ST ;
Goomer, RS ;
Ostrander, RV ;
Tontz, WL ;
Williams, SK ;
Amiel, D .
CLINICAL ORTHOPAEDICS AND RELATED RESEARCH, 2004, (420) :276-285
[8]
Bannasch H, 2005, PANMINERVA MED, V47, P53
[9]
Age related changes in human articular chondrocyte yield, proliferation and post-expansion chondrogenic capacity [J].
Barbero, A ;
Grogan, S ;
Schäfer, D ;
Heberer, M ;
Mainil-Varlet, P ;
Martin, I .
OSTEOARTHRITIS AND CARTILAGE, 2004, 12 (06) :476-484
[10]
Autologous chondrocyte implantation versus matrix-induced autologous chondrocyte implantation for osteochondral defects of the knee [J].
Bartlett, W ;
Skinner, JA ;
Gooding, CR ;
Carrington, RWJ ;
Flanagan, AM ;
Briggs, TWR ;
Bentley, G .
JOURNAL OF BONE AND JOINT SURGERY-BRITISH VOLUME, 2005, 87B (05) :640-645